ANATOMICAL DISTRIBUTION AND FUNCTION OF DOPAMINE-RECEPTORS IN THE KIDNEY

被引:139
作者
LOKHANDWALA, MF [1 ]
AMENTA, F [1 ]
机构
[1] UNIV ROMA TOR VERGATA, DIPARTIMENTO SANITA PUBBLICA & BIOL CELLULARE, ROME, ITALY
关键词
DOPAMINE; DA-1; RECEPTORS; DA-2; RENAL FUNCTION; HYPERTENSION; RENAL FAILURE; CELLULAR SIGNALING;
D O I
10.1096/fasebj.5.15.1683844
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopamine receptors of DA-1 and DA-2 subtypes are localized in various regions within the kidney including the renal vasculature (DA-1) as well as sympathetic nerve terminals innervating the renal blood vessels (DA-2). More recent studies using receptor-ligand binding and receptor autoradiography have shown that DA-1 receptors are localized at both the luminal and basolateral membranes at the level of the proximal tubules. Activation of these DA-1 receptors by dopamine and by selective DA-1 receptor agonists results in natriuresis and diuresis. The cellular signaling mechanisms responsible for this response appear to be DA-1 receptor-induced activation of adenylate cyclase and phospholipase C, which via the generation of various intracellular messenger systems cause inhibition of Na+-H+ antiport (luminal) and Na+, K+-ATPase (basolateral), respectively. Both of these events consequently inhibit sodium reabsorption leading to natriuresis and diuresis. It is also known that dopamine can be synthesized within proximal tubular cells from L-dopa, which is taken up from the tubular lumen, and this locally produced dopamine plays an important role in the regulation of sodium excretion particularly during increases in sodium intake. Furthermore, a defect in the renal dopaminergic mechanism may be one of the pathogenic factors in certain forms of hypertension. Finally, whereas DA-1 receptor agonists are shown to be of therapeutic benefit in the treatment of hypertension, heart failure, and acute renal failure, some selective DA-2 receptor agonists are effective antihypertensive agents.
引用
收藏
页码:3023 / 3030
页数:8
相关论文
共 67 条
[1]  
AMENTA F, 1990, J PHARMACOL EXP THER, V253, P246
[2]   AUTORADIOGRAPHIC LOCALIZATION OF DOPAMINE DA-1 RECEPTORS IN THE RAT RENAL VASCULATURE USING [H-3] SCH 23390 AS A LIGAND [J].
AMENTA, F ;
RICCI, A .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 (06) :373-383
[3]   DENSITY AND DISTRIBUTION OF DOPAMINE-RECEPTORS IN THE CARDIOVASCULAR-SYSTEM AND IN THE KIDNEY [J].
AMENTA, F .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 :S11-S18
[4]   ATTENUATED RENAL PRODUCTION OF DOPAMINE IN PATIENTS WITH LOW RENIN ESSENTIAL-HYPERTENSION [J].
AOKI, K ;
KIKUCHI, K ;
YAMAJI, I ;
NISHIMURA, M ;
HONMA, C ;
KOBAYAKAWA, H ;
YAMAMOTO, M ;
KUDOH, C ;
SHIMAZAKI, M ;
SAKAMOTO, T ;
WADA, A ;
IIMURA, O .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1989, 11 :403-409
[5]   DOPAMINE CAUSES INHIBITION OF NA+-K+-ATPASE ACTIVITY IN RAT PROXIMAL CONVOLUTED TUBULE SEGMENTS [J].
APERIA, A ;
BERTORELLO, A ;
SERI, I .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (01) :F39-F45
[6]   PRESENCE OF DOPAMINE-DEPENDENT ADENYLATE-CYCLASE ACTIVITY IN HUMAN RENAL CORTEX [J].
BALDI, E ;
PUPILLI, C ;
AMENTA, F ;
MANNELLI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (03) :351-356
[7]   USEFULNESS OF DOPEXAMINE HYDROCHLORIDE VERSUS DOBUTAMINE IN CHRONIC CONGESTIVE HEART-FAILURE AND EFFECTS ON HEMODYNAMICS AND URINE OUTPUT [J].
BAUMANN, G ;
FELIX, SB ;
FILCEK, SAL .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (11) :748-754
[8]  
BELL C, 1988, PERIPHERAL ACTIONS D
[9]   NA+-K+-ATPASE IS AN EFFECTOR PROTEIN FOR PROTEIN KINASE-C IN RENAL PROXIMAL TUBULE CELLS [J].
BERTORELLO, A ;
APERIA, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :F370-F373
[10]   EFFECT OF FENOLDOPAM IN DOGS WITH SPONTANEOUS RENAL-INSUFFICIENCY [J].
BROOKS, DP ;
GOLDSTEIN, R ;
KOSTER, PF ;
DEPALMA, PD ;
DICRISTO, M ;
KARPINSKI, K ;
HYNECK, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 184 (01) :195-199